{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:59:05Z","timestamp":1791295145227,"version":"4.1.0"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/mot.0b013e3283636c71","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T13:50:55Z","timestamp":1373377855000},"page":"463-469","source":"Crossref","is-referenced-by-count":39,"title":["Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation"],"prefix":"10.1097","volume":"18","author":[{"given":"Patricia","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R2-13-20211004","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2006.01521.x","article-title":"Transplanting the highly sensitized patient: the emory algorithm.","volume":"6","author":"Bray","year":"2006","journal-title":"Am J Transplant"},{"key":"R3-13-20211004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/TP.0b013e3181b04a5f","article-title":"Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program.","volume":"88","author":"Claas","year":"2009","journal-title":"Transplantation"},{"key":"R4-13-20211004","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.transproceed.2011.02.074","article-title":"Kidney transplantation for high-risk sensitized patients: the Heidelberg algorithm.","volume":"43","author":"Morath","year":"2011","journal-title":"Transplant Proc"},{"key":"R5-13-20211004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.healun.2012.02.024","article-title":"Editorial commentary: all that glitters is not gold.","volume":"31","author":"Shakar","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R6-13-20211004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.healun.2011.10.006","article-title":"Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices.","volume":"31","author":"Nikaein","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R7-13-20211004","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtcvs.2011.07.019","article-title":"Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.","volume":"142","author":"Arnaoutakis","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R8-13-20211004","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"Natural human leukocyte antigen antibodies found in nonalloimmunized healthy males.","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"R9-13-20211004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/TP.0b013e3181ac6198","article-title":"Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.","volume":"88","author":"Cai","year":"2009","journal-title":"Transplantation"},{"key":"R10-13-20211004","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"R11-13-20211004","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.humimm.2012.04.016","article-title":"Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation.","volume":"73","author":"Liu","year":"2012","journal-title":"Hum Immunol"},{"key":"R12-13-20211004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2012.10.012","article-title":"Modified solid-phase alloantibody detection for improved crossmatch prediction.","volume":"74","author":"Wahrmann","year":"2013","journal-title":"Hum Immunol"},{"key":"R13-13-20211004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MOT.0b013e3283028312","article-title":"Antibodies, isotypes and complement in allograft rejection.","volume":"13","author":"Bohmig","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R14-13-20211004","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/TP.0b013e31827b3dc3","article-title":"Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.","volume":"95","author":"Lachmann","year":"2013","journal-title":"Transplantation"},{"key":"R15-13-20211004","first-page":"318","article-title":"Annual literature review of donor-specific HLA antibodies after organ transplantation.","volume":"311-","author":"Kaneku","year":"2011","journal-title":"Clin Transpl"},{"key":"R16-13-20211004","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.TP.0000136966.63957.E2","article-title":"Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential.","volume":"78","author":"Kushihata","year":"2004","journal-title":"Transplantation"},{"key":"R17-13-20211004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-6143.2007.02034.x","article-title":"High-tech detection of HLA antibodies and complement: prospects and limitations.","volume":"8","author":"Schaub","year":"2008","journal-title":"Am J Transplant"},{"key":"R18-13-20211004","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5858\/2006-130-368-MHCABH","article-title":"Measuring human complement activation by HLA antibodies.","volume":"130","author":"Watanabe","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R19-13-20211004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R20-13-20211004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients.","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R21-13-20211004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1744-313X.2012.01147.x","article-title":"The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera.","volume":"40","author":"Weinstock","year":"2013","journal-title":"Int J Immunogenet"},{"key":"R22-13-20211004","first-page":"280","article-title":"Antibody-mediated rejection in the liver allograft.","volume":"17","author":"Hubscher","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"R23-13-20211004","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation.","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"R24-13-20211004","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2012.02810.x","article-title":"Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation.","volume":"32","author":"Iacob","year":"2012","journal-title":"Liver Int"},{"key":"R25-13-20211004","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant.","volume":"11","author":"OLeary","year":"2011","journal-title":"Am J Transplant"},{"key":"R26-13-20211004","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-6143.2010.03414.x","article-title":"The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.","volume":"11","author":"Musat","year":"2011","journal-title":"Am J Transplant"},{"key":"R27-13-20211004","first-page":"171","article-title":"Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring Am J T","volume":"12","author":"Lunz","year":"2012","journal-title":"ransplant"},{"key":"R28-13-20211004","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trim.2011.08.005","article-title":"Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.","volume":"26","author":"Ali","year":"2012","journal-title":"Transpl Immunol"},{"key":"R29-13-20211004","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year.","volume":"12","author":"Taner","year":"2012","journal-title":"Am J Transplant"},{"key":"R30-13-20211004","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/TP.0b013e31820000a1","article-title":"Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants.","volume":"90","author":"Farmer","year":"2010","journal-title":"Transplantation"},{"key":"R31-13-20211004","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1111\/j.1600-6143.2012.04237.x","article-title":"Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.","volume":"12","author":"Abu-Elmagd","year":"2012","journal-title":"Am J Transplant"},{"key":"R32-13-20211004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/TP.0b013e318229f752","article-title":"Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation.","volume":"92","author":"Tsai","year":"2011","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"R33-13-20211004","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1600-6143.2012.04238.x","article-title":"Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching.","volume":"12","author":"Hawksworth","year":"2012","journal-title":"Am J Transplant"},{"key":"R34-13-20211004","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1600-6143.2011.03467.x","article-title":"Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liverkidney transplants.","volume":"11","author":"Dar","year":"2011","journal-title":"Am J Transplant"},{"key":"R35-13-20211004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0966-3274(94)90080-9","article-title":"Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.","volume":"2","author":"Saidman","year":"1994","journal-title":"Transpl Immunol"},{"key":"R36-13-20211004","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ajt.12147","article-title":"Class II alloantibody and mortality in simultaneous liver-kidney transplantation.","volume":"13","author":"OLeary","year":"2013","journal-title":"Am J Transplant"},{"key":"R37-13-20211004","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/TP.0b013e31817c4cb8","article-title":"Human leukocyte antigen antibodies and chronic rejection: from association to causation.","volume":"86","author":"Terasaki","year":"2008","journal-title":"Transplantation"},{"key":"R38-13-20211004","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2006.01503.x","article-title":"Posttransplant anti-HLA class II antibodies as risk factor for late kidney allograft failure.","volume":"6","author":"Campos","year":"2006","journal-title":"Am J Transplant"},{"key":"R39-13-20211004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/TP.0b013e3182543950","article-title":"De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.","volume":"94","author":"Willicombe","year":"2012","journal-title":"Transplantation"},{"key":"R40-13-20211004","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.tp.0000180564.14050.49","article-title":"The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome.","volume":"80","author":"Tambur","year":"2005","journal-title":"Transplantation"},{"key":"R41-13-20211004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R42-13-20211004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"key":"R43-13-20211004","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1399-3046.2010.01435.x","article-title":"HLA antibodies in pediatric heart transplantation.","volume":"15","author":"Ho","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R44-13-20211004","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl"},{"key":"R46-13-20211004","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R47-13-20211004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0b013e31823bb647","article-title":"Early subclinical rejection as a risk factor for late chronic humoral rejection.","volume":"93","author":"Moreso","year":"2012","journal-title":"Transplantation"},{"key":"R48-13-20211004","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.healun.2012.08.011","article-title":"Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: implications for chronic lung rejection.","volume":"31","author":"Takenaka","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R49-13-20211004","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/TP.0b013e318244f7b8","article-title":"Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.","volume":"93","author":"Hodges","year":"2012","journal-title":"Transplantation"},{"key":"R50-13-20211004","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"R51-13-20211004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOT.0b013e3283352a50","article-title":"Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.","volume":"15","author":"Sis","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"R52-13-20211004","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.humimm.2012.07.330","article-title":"Role of complement and NK cells in antibody mediated rejection.","volume":"73","author":"Akiyoshi","year":"2012","journal-title":"Hum Immunol"},{"key":"R53-13-20211004","first-page":"332","article-title":"Antibodies to human leukocyte antigens in lung transplantation.","volume":"327-","author":"Hachem","year":"2011","journal-title":"Clin Transpl"},{"key":"R54-13-20211004","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/TP.0b013e31827afb0f","article-title":"Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.","volume":"95","author":"Brugiere","year":"2013","journal-title":"Transplantation"},{"key":"R55-13-20211004","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.healun.2010.10.005","article-title":"HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.","volume":"30","author":"Peltz","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R56-13-20211004","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/TP.0b013e318211d2f4","article-title":"A role for antibodies to human leukocyte antigens, collagen-V, and K-alpha1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.","volume":"91","author":"Nath","year":"2011","journal-title":"Transplantation"},{"key":"R57-13-20211004","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"key":"R58-13-20211004","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant"},{"key":"R59-13-20211004","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.healun.2011.01.708","article-title":"Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.","volume":"30","author":"Saini","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R60-13-20211004","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis.","volume":"17","author":"Aguilera","year":"2011","journal-title":"Liver Transplant"},{"key":"R61-13-20211004","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","article-title":"HLA and MICA: targets of antibody-mediated rejection in heart transplantation.","volume":"91","author":"Zhang","year":"2011","journal-title":"Transplantation"},{"key":"R62-13-20211004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2249.2011.04486.x","article-title":"A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.","volume":"167","author":"Tiriveedhi","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R63-13-20211004","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"R64-13-20211004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation.","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R65-13-20211004","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/lt.23481","article-title":"Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance.","volume":"18","year":"2012","journal-title":"Liver Transpl"},{"key":"R66-13-20211004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ppedcard.2011.06.009","article-title":"Immune monitoring of pediatric heart transplant recipients through serial donor specific antibody testing: an initial experience and review of the literature.","volume":"32","author":"Gambetta","year":"2011","journal-title":"Prog Pediatr Cardiol"},{"key":"R67-13-20211004","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1600-6143.2006.01657.x","article-title":"Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts.","volume":"7","author":"Haas","year":"2007","journal-title":"Am J Transplant"},{"key":"R68-13-20211004","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201308000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:07:26Z","timestamp":1688342846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201308000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283636c71","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}